(Q33403361)

26 July 2017

title

Renal and neurological involvement in typical Shiga toxin-associated HUS. (English)

1 reference

26 July 2017

Howard Trachtman

1

0 references

author name string

Catherine Austin

series ordinal

2

1 reference

26 July 2017

Maria Lewinski

series ordinal

3

1 reference

26 July 2017

Rolf A K Stahl

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

18 September 2012

1 reference

Nature Reviews Nephrology

26 July 2017

published in

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

658-669

1 reference

Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Clinical practice. Today's understanding of the haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Hemolytic Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin 1 causes direct renal injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin 2 targets the murine renal collecting duct epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with polyuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Complement in typical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Hemolytic uremic syndrome: epidemiological and clinical features of a pediatric population in Tuscany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Multiple cavitations in posterior reversible leukoencephalopathy syndrome associated with hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Hemolytic uremic syndrome (HUS)--incidence and etiologies at a regional Children's Hospital in 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Open-Source Genomic Analysis of Shiga-Toxin–Producing E. coli O104:H4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

German outbreak of Escherichia coli O104:H4 associated with sprouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Eculizumab in severe Shiga-toxin-associated HUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

"HUS diary" of a German nephrologist during the current EHEC outbreak in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Therapy: Azithromycin and decolonization after HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Editorial Commentary: Escherichia coli O104:H4 and Hemolytic Uremic Syndrome: The Analysis Begins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

The hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.196

The clinical course and long-term outcome of hemolytic-uremic syndrome in children

31 March 2020

1 reference

12 December 2020

Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits

1 reference

12 December 2020

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

1 reference

12 December 2020

Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.

1 reference

12 December 2020

Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis

1 reference

12 December 2020

Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies

1 reference

12 December 2020

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms

1 reference

12 December 2020

Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.196

1 reference

26 July 2017

1 reference